Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.50p +0.64% 78.60p 1,227,746 16:35:07
Bid Price Offer Price High Price Low Price Open Price
78.50p 79.20p 79.80p 77.30p 77.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 118.21 22.80 3.69 21.3 407.5

Alliance Pharma (APH) Latest News

More Alliance Pharma News
Alliance Pharma Takeover Rumours

Alliance Pharma (APH) Share Charts

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart

Intraday Alliance Pharma Chart

Intraday Alliance Pharma Chart

Alliance Pharma (APH) Discussions and Chat

Alliance Pharma Forums and Chat

Date Time Title Posts
21/5/201914:21Alliance Pharma pays Dividends1,513
21/8/201817:36A Canadian Stock Worth Watching1
11/6/201810:21Unexpected-
07/11/201615:35Alliance Pharma plc1
15/7/201310:15ALLIANCE PHARMA – 2005 Strong Riser611

Add a New Thread

Alliance Pharma (APH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-05-22 15:51:5378.563,4382,701.03O
2019-05-22 15:35:0778.601,6881,326.77UT
2019-05-22 15:29:3179.20293232.06AT
2019-05-22 15:22:5479.20617488.66AT
2019-05-22 15:21:4679.001,260995.40O
View all Alliance Pharma trades in real-time

Alliance Pharma (APH) Top Chat Posts

DateSubject
22/5/2019
09:20
Alliance Pharma Daily Update: Alliance Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 78.10p.
Alliance Pharma Plc has a 4 week average price of 75p and a 12 week average price of 62p.
The 1 year high share price is 102.50p while the 1 year low share price is currently 59.20p.
There are currently 518,411,586 shares in issue and the average daily traded volume is 1,968,922 shares. The market capitalisation of Alliance Pharma Plc is £407,471,506.60.
11/4/2019
08:40
winnings1: The share price will go well above 80p in the coming months, the fundamentals dictate a target price in region of 80p-90p. IMO.
09/4/2019
17:48
mazarin: We all have our reasons for selling, some times to try another sector, other times time to ‘prove you’re simply not wedded’ to a share as I have been guilty of here, however I once sold APH at 64p having bought some at 14p and 26p several years earlier. My latest entry was to buy back in at 83p having seen it tumble from highs of around £1.02p and judged (wrongly) it was time to get back in and now see it’s slowly recovering. APH has had its share of disappointments since I first bought into it 10 years ago. Eg. I recall the Sanofi disaster (floods in Canada) had an immediate and sudden negative effect on APH and took several years for its share price to recover. Recently I was £9k down in just a matter of months, but during my long experience of holding, I believe these events are temporary setbacks and remain confident things will in the long term improve. Ever the optimist
26/3/2019
07:28
saeed45: Hopefully will see an increase in share price and go back where it should be
19/3/2019
15:38
saeed45: What should we expect on the share price from the announcement next week?
15/3/2019
08:52
winnings1: Every reduction in a major holding has to be announced to the Market, In the absence of any such announcements, the explanation for the stubborn low share price could be impatient fickle private investors selling on minor rises looking for a fast buck elsewhere....at a risk of a fast loss. APH is a steady horse, growing at a steady rate, perhaps somewhat boring but safer than most. However, the low share price will not be forever, a positive RNS from APH (could come anytime) will drive the share price substantially north. IMO, Winnings.
07/3/2019
18:18
winnings1: APH's shares continue to trade below 70p, yet realistically and based on fundamentals the shares deserve to trade above 80p. I hold long term, therefore I am not unduly perturbed at the current under-performance of the share price which in my view is unlikely to last for very much longer.
15/1/2019
13:56
winnings1: Whatever the reason for sellers exceeding buyers, the Company's performance is unaffected. I hold a good number of shares, I have no intentions to sell, I maintain the shares are worth 80p+ and I maintain that share price recovery is inevitable as there is no knowledge nor expectation of deterioration in the company's performance. Cheers.
18/10/2018
16:36
cisk: Livingbridge aren’t even a major shareholder, there has been no RNS re their holding, I don’t think they were even over 3% and I’m sorry I’m not going to sit through their webinar to find out what they said. For those that are concerned, take a look at Livingbridge’s top 10 holdings - nothing much to write home about. And they mirror their benchmark and I wouldn’t say their performance is spectacular. So I just don’t see the performance of an average fund impacting the share price to that extent. So personally I care not a jot what this fund does. I do care about upcoming launches and the pending good news flow coming from the company, and Nizoral sales getting going and feeding through to the bottom line. Really the share price got ahead of itself this year, it’s probably oversold now but it’s an opportunity to top up, if you feel like doing so in the current market. Alliance has grown steadily, and through deals etc it’s not as reliant on a single product as it once was.
18/10/2018
12:13
winnings1: Remarkable how low the share price of APH has gone (65p-66p today). In the current uncertain times (political and financial) the shares of APH should be at a premium as the Company operates in recession proof territory, Demand for medicines will continue to go up, whatever the state of the global economy.
24/7/2017
10:24
arf dysg: I notice that the International Misery Fund said that we're screwed, blued and tattooed. Putting it in slightly more formal language, the predictions for growth in the USA and the UK have gone down a little. Perhaps that's why everyone's taking drugs as if there's no tomorrow, so the APH share price has gone up.
Alliance Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
APH
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190523 02:53:32